Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus.
about
TMG-123, a novel glucokinase activator, exerts durable effects on hyperglycemia without increasing triglyceride in diabetic animal modelsIdentification of mangiferin as a potential Glucokinase activator by structure-based virtual ligand screening.Molecular targeting of the GK-GKRP pathway in diabetes.Investigational insulin secretagogues for type 2 diabetes.Translational Modeling and Simulation in Supporting Early-Phase Clinical Development of New Drug: A Learn-Research-Confirm Process.Molecular reductions in glucokinase activity increase counter-regulatory responses to hypoglycemia in mice and humans with diabetes
P2860
Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus.
@en
type
label
Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus.
@en
prefLabel
Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus.
@en
P1476
Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus
@en
P2093
Ajmer Singh Grewal
Bhupinder Singh Sekhon
P304
P356
10.2174/1389557514666140722082713
P50
P577
2014-01-01T00:00:00Z